Mass General Brigham Medicare Advantage plan drops Dana-Farber
Eldon Clingan has had the same cancer specialist at Dana-Farber Cancer Institute for more than two decades. He…
New study uncovers bacterial route to testosterone production
Many prostate cancers depend on androgen hormones, including testosterone, to grow. That is why treatments for advanced disease…
“I Have Changed”: Lisa Ray Reveals How Her Fitness Goals Changed In Her 50s
Lisa Ray recently opened up about how her idea of fitness has changed in her 50s. The actress…
Researchers find greater microplastic burden in lung cancer patients
People with lung cancer are more likely to have microplastics in their lungs and to have larger quantities…
Microscopic peptide droplets reduce colorectal tumor growth in mice
Scientists from Nanyang Technological University, Singapore (NTU Singapore) have developed microscopic peptide droplets that deliver large amounts of…
IBD patients with family cancer history more likely to develop colorectal cancer
People with inflammatory bowel disease (IBD) who have several close relatives with colorectal cancer are significantly more likely…
Early-onset bowel cancer shows distinct biological and clinical features
One of Australia’s largest real world studies of younger adults with advanced bowel cancer has identified important differences…
Social media messages could empower parents to prevent teen vaping
Parents are an important line of defense against teen vaping, yet many lack the knowledge and tools needed…
Routine referral of prostate cancer patients to a cardiovascular specialist fails to cut cardiac events
Men with prostate cancer have a high risk of heart disease, especially when treated with hormone therapy. A…
Cadre of radiopharmaceuticals experts pushes the bounds in cancer therapy
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of…
Breast cancer survivors could avoid lifelong heart medication, research suggests
Many breast cancer survivors whose treatment caused them to develop problems with their heart function can safely stop their medication after their heart recovers and most won’t need to continue treatment long-term, according to…
FDA approves daraxonrasib for patients with metastatic pancreatic cancer
The U.S. Food and Drug Administration (FDA) has approved daraxonrasib for patients whose pancreatic cancer has spread to…